Long-term response to first-line bevacizumab-based therapy in patients with metastatic breast cancer: results of the observational “LORENA” study

BACKGROUND: Randomized controlled trials of the first-line combination of bevacizumab and chemotherapy in patients with metastatic breast cancer (MBC) have shown improvements in tumor response and progression-free survival (PFS). OBJECTIVE: The aim of this ambispective, observational study (LORENA)...

Descripción completa

Detalles Bibliográficos
Autores principales: Redondo, Andrés, Ramos Vázquez, Manuel, Manso, Luis, Gil Gil, Miguel J, Garau Llinas, Isabel, García-Garre, Elisa, Rodríguez, César A, Chacón, José Ignacio, López-Vivanco, Guillermo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149976/
https://www.ncbi.nlm.nih.gov/pubmed/30271167
http://dx.doi.org/10.2147/OTT.S170303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149976/
https://www.ncbi.nlm.nih.gov/pubmed/30271167
http://dx.doi.org/10.2147/OTT.S170303

Ejemplares similares